Sanofi (SNY) Net Income - Minority (2009)

Sanofi (SNY) posted Net Income - Minority of $119.6 million for Q4 2009, down 26.63% sequentially from $163.0 million in Q3 2009.

Sanofi (SNY) Net Income - Minority (2009) Analysis & Trends

Sanofi (SNY) has 1 years of Net Income - Minority data on file, last reported at $119.6 million in Q4 2009.

Quarterly Net Income - Minority changed N/A year-over-year to $119.6 million in Q4 2009, while the trailing twelve-month figure through Dec 2009 was $119.6 million (changed N/A YoY) and the FY2009 annual result came in at $113.0 million, changed N/A from the prior year.
Net Income - Minority slipped to $119.6 million in Q4 2009 per SNY's latest filing, from $163.0 million in the prior quarter.
The five-year high for Net Income - Minority was $163.0 million in Q3 2009, with the low at $119.6 million in Q4 2009.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Income - Minority (Qtr)
1	Eli Lilly	1,066.16 Bn	1,060.88 Bn	16.22 Bn	-
2	Johnson & Johnson	611.69 Bn	589.64 Bn	15.96 Bn	-
3	AbbVie	444.34 Bn	434.99 Bn	10.78 Bn	-
4	Astrazeneca	284.94 Bn	277.05 Bn	12.61 Bn	-
5	Merck	224.23 Bn	218.58 Bn	12.09 Bn	-
6	Amgen	195.12 Bn	183.08 Bn	5.87 Bn	-
7	Gilead Sciences	156.45 Bn	148.73 Bn	5.52 Bn	-
8	Pfizer	136.01 Bn	123.24 Bn	-1.21 Bn	-
9	Novartis Ag	113.45 Bn	113.67 Bn	-	-
10	Sanofi	-	-	9.49 Bn	-

Download Data